A wolfberry peptide with the function of reducing triglyceride and high blood pressure, and a preparation method and application thereof

By combining specific compound microbial agents and fermentation aids, the active ingredients in wolfberry peptides can be precisely controlled, solving the problem of unstable effects of wolfberry peptides in existing technologies. This achieves more efficient regulation of blood sugar, blood lipids and blood pressure, and improves the application effect of wolfberry peptides in the treatment of metabolic syndrome.

CN121294554BActive Publication Date: 2026-11-10CHINA BUSINESS SILK ROAD IOT TECH CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202511394126.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-09-28
Publication Date
2026-11-10
Estimated Expiration
2045-09-28

AI Technical Summary

Technical Problem

Existing technologies lack precise identification and control of the active ingredients in wolfberry peptides, resulting in unstable effects.

Method used

Fermentation is carried out using a specific type and ratio of compound microbial agents, combined with fermentation aids. Through steps such as anaerobic fermentation, ultrasonic treatment, and multi-stage membrane filtration, the formation of active peptides in wolfberry peptides, especially glutathione and wolfberry cyclic peptide-1, is precisely controlled.

Benefits of technology

It significantly increased the content and diversity of active peptides in wolfberry peptides, enhanced their synergistic effect in regulating blood sugar, blood lipids and blood pressure, and improved the overall efficacy and stability of the product in preventing and treating metabolic syndrome.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005617250740000121
    Figure BDA0005617250740000121
Patent Text Reader

Abstract

The present application belongs to the technical field of preparation of wolfberry peptide, and particularly relates to a wolfberry peptide with the effect of reducing three highs, and a preparation method and application thereof. The preparation method of the wolfberry peptide comprises the following steps: (1) drying fresh wolfberry, crushing, and obtaining wolfberry powder; (2) mixing the wolfberry powder, water and fermentation aid, sterilizing, obtaining a mixture, adding a compound microbial inoculum to the mixture, anaerobic fermentation, sterilizing, and obtaining a fermentation product; (3) ultrasonicating the fermentation product, centrifuging, and collecting the upper liquid; (4) sequentially filtering the upper liquid using a microfiltration membrane and eluting the upper liquid from a macroporous adsorption resin column, and obtaining a purified solution; and (5) reducing pressure concentration of the purified solution, spray drying, and obtaining the wolfberry peptide with the effect of reducing three highs. The wolfberry peptide prepared by the present application has high contents of glutathione and wolfberry cyclic peptide-1, and the wolfberry peptide can be used for preparing products for preventing and treating hypertension, hyperlipidemia and hyperglycemia.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of wolfberry peptide preparation technology, specifically relating to a wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol, its preparation method, and its application. Background Technology

[0002] Peptides derived from animal and plant proteins can lower blood pressure by inhibiting angiotensin-converting enzyme (ACE) activity, regulate blood lipids by modulating lipid metabolism-related enzymes (such as HMG-CoA reductase) or promoting cholesterol excretion, and regulate blood sugar by enhancing insulin sensitivity, inhibiting α-sucrase activity to delay carbohydrate absorption, or protecting pancreatic β-cell function. Goji berry peptides have certain potential for antioxidant, immunomodulatory, and metabolic improvement effects, and possess significant market potential.

[0003] Chinese patent CN106868081A discloses a method for extracting wolfberry peptides. By improving the preparation process, the raw materials undergo multiple enzymatic hydrolysis and filtration, which not only improves the utilization rate of wolfberries but also increases the extraction rate of wolfberry peptides. This method is characterized by low cost, high output, and ease of large-scale promotion.

[0004] Chinese patent CN117737170A discloses a method for extracting wolfberry peptides. This method can effectively improve the extraction quality and efficiency of wolfberry peptides, thereby reducing the waste of raw materials and lowering the preparation cost of wolfberry peptides.

[0005] Glutathione (GSH) is a tripeptide composed of glutamic acid, cysteine, and glycine, widely present in human cells and an important endogenous antioxidant. It plays a crucial role in maintaining cellular redox balance, detoxification, and immune regulation. Patent CN101289494B discloses a cyclic peptide compound with vasodilatory effects, its preparation method, and its uses. Numerous experiments have demonstrated that this cyclic peptide compound has a strong vasodilatory effect. The article "Lycium barbarum cyclic peptide regulates NLRP3 and NF-κB signaling pathways to alleviate BaP-induced airway epithelial cell inflammatory damage" found that Lycium barbarum cyclic peptides regulate inflammatory cytokines. While existing technologies optimize the preparation of Lycium barbarum peptides through enzymatic hydrolysis, they lack precise identification of active ingredients, fail to determine the specific active peptides that truly exert efficacy in the mixture, and lack precise control over key active peptides, resulting in unstable effects of Lycium barbarum peptides. Summary of the Invention

[0006] The purpose of this invention is to provide a wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol, as well as its preparation method and application. By precisely controlling specific types of active peptides, the efficacy of wolfberry peptides can be improved.

[0007] To achieve the above objectives, the present invention provides the following technical solution:

[0008] The first aspect provides a method for preparing wolfberry peptides with the effect of lowering blood pressure, blood sugar, and cholesterol, including the following steps:

[0009] (1) Dry fresh goji berries, pulverize them, and obtain goji berry powder;

[0010] (2) Mix wolfberry powder, water and fermentation aid, sterilize to obtain a mixture, add compound microbial agent to the mixture, anaerobic fermentation, sterilize to obtain fermentation product;

[0011] (3) Sonicate the fermentation product, centrifuge, and collect the supernatant liquid;

[0012] (4) The upper liquid was filtered sequentially using a microfiltration membrane and eluted with a macroporous adsorption resin column to obtain a purified solution.

[0013] (5) The purified solution was concentrated under reduced pressure and spray-dried to obtain wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol.

[0014] Preferably, the compound microbial agent includes Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110, and Lactobacillus gasseri LG-G12.

[0015] Preferably, the ratio of viable Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110, and Lactobacillus gasseri LG-G12 in the compound microbial agent is (0.3-0.5):(0.8-1.0):(1.5-1.7).

[0016] Preferably, the dosage of the compound microbial agent is (5-8)×10. 7 CFU / mL mixture.

[0017] The preferred anaerobic fermentation conditions are: anaerobic fermentation at 35-40℃ for 72-84 hours.

[0018] This invention utilizes a compound microbial agent to ferment wolfberry, which can increase the content and diversity of active peptides in wolfberry peptides, while significantly improving the production efficiency of glutathione and wolfberry cyclic peptide-1. The compound microbial agent of this invention not only secretes multiple enzymes during its growth process, but also continuously produces various enzymes and engages in metabolic activities, performing multi-step processing of the substrate. Furthermore, the types and proportions of enzymes produced by the compound microorganisms change dynamically at different stages. The specific types and proportions of compound microbial agents used in this invention not only secrete multiple enzymes to achieve gentle and targeted protein hydrolysis, but also synthesize beneficial functional substances through metabolic activities, enhancing the bioavailability of the original active ingredients of wolfberry.

[0019] Preferably, the fermentation aid comprises sucrose, broccoli stem extract, calcium nitrate, calcium chloride and arginine in a mass ratio of (10-12):(3-4):(1-3):(0.5-1.5):(0.1-0.3).

[0020] Preferably, the preparation method of broccoli stalk extract includes the following steps:

[0021] S1: Wash the broccoli stems, let them air dry until there are no liquid droplets on the surface, add water, grind, and obtain a slurry;

[0022] S2: Sonicate the slurry at 40-50℃ and 50-60Hz for 20-30 minutes, centrifuge, collect the centrifuged liquid, concentrate under reduced pressure, and spray dry to obtain broccoli stem extract.

[0023] This invention selects fermentation aids as nutrient components, which can maintain an ideal fermentation environment during the fermentation process, provide necessary nutrients, help the compound microbial agent grow and metabolize, and thus improve its ability to biosynthesize active substances. In addition, the added fermentation aids can also affect the ability of microorganisms to produce specific enzymes and affect the activity of enzymes, thereby helping to produce glutathione and wolfberry cyclic peptide-1.

[0024] Preferably, the ultrasonic conditions are: ultrasonic power of 350-400W, ultrasonic frequency of 32-35kHz, ultrasonic temperature of 30-40℃, and ultrasonic time of 1-2h.

[0025] The second aspect provides a wolfberry peptide prepared by the aforementioned method, which has the effect of lowering blood pressure, blood sugar, and cholesterol.

[0026] The third aspect provides the application of the aforementioned wolfberry peptide, which has the effect of lowering blood pressure, blood sugar, and cholesterol.

[0027] Compared with the prior art, the advantages and beneficial effects of the present invention are as follows:

[0028] 1. The wolfberry peptides (wolfberry peptide complex) prepared in this invention are not only rich in highly active glutathione and wolfberry cyclic peptide-1, but also retain a variety of synergistically active bioactive small peptides through optimized processes. Among them, wolfberry cyclic peptide has an auxiliary effect on lowering blood pressure, blood sugar, and cholesterol. Glutathione exerts a strong antioxidant effect, significantly reducing oxidative stress damage to tissues such as the pancreas and vascular endothelium, improving insulin resistance, and inhibiting lipid peroxidation, thereby synergistically regulating blood sugar and lipid metabolism. Wolfberry cyclic peptide-1 effectively dilates blood vessels and lowers blood pressure. The synergistic effect of multiple active ingredients in wolfberry peptides can more comprehensively intervene in the occurrence and development mechanism of "three highs" (hypertension, hyperlipidemia, and hyperglycemia), improving the overall efficacy and stability of the product in the prevention and adjuvant treatment of metabolic syndrome.

[0029] 2. This invention utilizes a compound microbial agent to ferment wolfberry, which can increase the content and diversity of active peptides in wolfberry peptides, while significantly improving the production efficiency of glutathione and wolfberry cyclic peptide-1. The specific types and proportions of compound microbial agents used in this invention not only secrete various proteases to achieve mild and targeted protein hydrolysis, but also synthesize beneficial functional substances through metabolic activities, enhancing the bioavailability of the original active ingredients of wolfberry.

[0030] 3. The present invention selects fermentation aids as nutrient components, which can maintain an ideal fermentation environment during the fermentation process, provide necessary nutrients, help the compound microbial agent grow and metabolize, and thus improve its ability to biosynthesize active substances. In addition, the added fermentation aids can also affect the ability of microorganisms to produce specific enzymes and affect the activity of enzymes, thereby helping to produce glutathione and wolfberry cyclic peptide-1. Detailed Implementation

[0031] The technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0032] All raw materials used in the following embodiments of the present invention are commercially available products:

[0033] Lactobacillus acidophilus A-G80, catalog number CCTCCM2013337, manufactured by Junyao Runying Biotechnology (Shanghai) Co., Ltd. Lactobacillus paracasei LPc-G110, catalog number CCTCCM2013691, manufactured by Junyao Runying Biotechnology (Shanghai) Co., Ltd. Lactobacillus gasseri LG-G12, catalog number CCTCCM2019829, manufactured by Junyao Runying Biotechnology (Shanghai) Co., Ltd.

[0034] Example 1

[0035] This embodiment provides a wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol. The preparation method includes the following steps:

[0036] (1) Dry fresh wolfberries (variety: Ningqi No. 1) to a moisture content of 8wt%, and grind them to less than 100 mesh to obtain wolfberry powder;

[0037] (2) Mix wolfberry powder, water, and fermentation aid in a mass ratio of 1:9:2.4, sterilize, and obtain a mixture. Add a compound microbial agent to the mixture at a dosage of 6×10⁻⁶. 7The CFU / mL mixture was fermented at 37℃ for 80 hours under anaerobic conditions, followed by sterilization to obtain the fermentation product. The compound microbial agent included Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110, and Lactobacillus gasseri LG-G12, with a viable count ratio of 0.4:1:1.6 for Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110, and Lactobacillus gasseri LG-G12. The fermentation aids included sucrose, broccoli stalk extract, calcium nitrate, calcium chloride, and arginine in a mass ratio of 11:3.2:2:1:0.2.

[0038] (3) The fermentation product was sonicated with an ultrasonic power of 380W, an ultrasonic frequency of 334kHz, an ultrasonic temperature of 35℃, an ultrasonic time of 1.5h, a centrifugation speed of 2600r / min, and centrifugation for 30min. The upper liquid was collected.

[0039] (4) The permeate was collected using a microfiltration membrane with a molecular weight of 35kD at a pressure of 5 bar and a temperature of 40°C. The permeate was collected using a microfiltration membrane with a molecular weight of 6kD at a pressure of 8 bar and a temperature of 30°C. The retentate was eluted using a macroporous adsorption resin column (filled with D101 resin and AB-8 resin in a mass ratio of 3:4) at a flow rate of 3 BV / h. After the column loading was completed, it was eluted with 2 BV of 30 (v / v)% ethanol aqueous solution to obtain the elution solution. After de-alcoholization, the purified solution was obtained.

[0040] (5) The purified solution was concentrated under reduced pressure to a solid content of 35wt%, and spray-dried. The drying conditions were set as follows: inlet temperature 160℃ and outlet temperature 80℃ to obtain wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol.

[0041] The preparation method of broccoli stalk extract includes the following steps:

[0042] S1: Wash the broccoli stems (collected from the market, the discarded parts after removing the broccoli florets) with clean water, let them air dry naturally until there are no liquid droplets on the surface, add 3 times the weight of water, and grind them under ice bath conditions until the particle size is less than 100μm to obtain a slurry;

[0043] S2: The slurry was sonicated at 45℃ and 55Hz for 25 min, then centrifuged at 3000 rpm for 18 min. The centrifuged liquid was collected, concentrated under reduced pressure, and spray-dried to obtain broccoli stem extract with a water content of 2.03 wt%.

[0044] Example 2

[0045] This embodiment provides a wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol. The preparation method includes the following steps:

[0046] (1) Dry fresh wolfberries (variety: Ningqi No. 1) to a moisture content of 8wt%, and grind them to less than 100 mesh to obtain wolfberry powder;

[0047] (2) Mix wolfberry powder, water, and fermentation aid in a mass ratio of 1:7:2, sterilize, and obtain a mixture. Add a compound microbial agent to the mixture at a dosage of 5×10⁻⁶. 7 The CFU / mL mixture was fermented at 35℃ for 72 hours under anaerobic conditions, followed by sterilization to obtain the fermentation product. The compound microbial agent included Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110, and Lactobacillus gasseri LG-G12, with a viable count ratio of 0.3:0.8:1.5 for Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110, and Lactobacillus gasseri LG-G12. The fermentation aids included sucrose, broccoli stalk extract, calcium nitrate, calcium chloride, and arginine in a mass ratio of 10:3:1:0.5:0.1.

[0048] (3) The fermentation product was sonicated with an ultrasonic power of 350W, an ultrasonic frequency of 32kHz, an ultrasonic temperature of 30℃, an ultrasonic time of 1h, a centrifugation speed of 2600r / min, and centrifugation for 30min. The upper liquid was collected.

[0049] (4) The permeate was collected using a microfiltration membrane with a molecular weight of 35kD at a pressure of 5 bar and a temperature of 40°C. The permeate was collected using a microfiltration membrane with a molecular weight of 6kD at a pressure of 8 bar and a temperature of 30°C. The retentate was eluted using a macroporous adsorption resin column (filled with D101 resin and AB-8 resin in a mass ratio of 3:4) at a flow rate of 3 BV / h. After the column loading was completed, it was eluted with 2 BV of 30 (v / v)% ethanol aqueous solution to obtain the elution solution. After de-alcoholization, the purified solution was obtained.

[0050] (5) The purified solution was concentrated under reduced pressure to a solid content of 30 wt%, and spray-dried. The drying conditions were set as follows: inlet temperature 160 ℃ and outlet temperature 80 ℃, to obtain wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol.

[0051] The preparation method of broccoli stalk extract includes the following steps:

[0052] S1: Wash the broccoli stems (collected from the market, the discarded parts after removing the broccoli florets) with clean water, let them air dry naturally until there are no liquid droplets on the surface, add 3 times the weight of water, and grind them under ice bath conditions until the particle size is less than 100μm to obtain a slurry;

[0053] S2: The slurry was sonicated at 40℃ and 50Hz for 20 min, then centrifuged at 3000 rpm for 18 min. The centrifuged liquid was collected, concentrated under reduced pressure, and spray-dried to obtain broccoli stem extract with a water content of 1.83 wt%.

[0054] Example 3

[0055] This embodiment provides a method for preparing wolfberry peptides with the effect of lowering blood pressure, blood sugar, and cholesterol, including the following steps:

[0056] (1) Dry fresh wolfberries (variety: Ningqi No. 1) to a moisture content of 8wt%, and grind them to less than 100 mesh to obtain wolfberry powder;

[0057] (2) Mix wolfberry powder, water, and fermentation aid in a mass ratio of 1:10:3, sterilize, and obtain a mixture. Add a compound microbial agent to the mixture at a dosage of 8 × 10⁻⁶. 7 The CFU / mL mixture was fermented at 40℃ for 84 hours under anaerobic conditions, followed by sterilization to obtain the fermentation product. The compound microbial agent included Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110, and Lactobacillus gasseri LG-G12, with a viable count ratio of 0.5:1:1.7 for Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110, and Lactobacillus gasseri LG-G12. The fermentation aids included sucrose, broccoli stalk extract, calcium nitrate, calcium chloride, and arginine in a mass ratio of 12:4:3:1.5:0.3.

[0058] (3) The fermentation product was sonicated with an ultrasonic power of 400W, an ultrasonic frequency of 35kHz, an ultrasonic temperature of 40℃, an ultrasonic time of 2h, a centrifugation speed of 2600r / min, and centrifugation for 30min. The upper liquid was collected.

[0059] (4) The permeate was collected using a microfiltration membrane with a molecular weight of 35kD at a pressure of 5 bar and a temperature of 40°C. The permeate was collected using a microfiltration membrane with a molecular weight of 6kD at a pressure of 8 bar and a temperature of 30°C. The retentate was eluted using a macroporous adsorption resin column (filled with D101 resin and AB-8 resin in a mass ratio of 3:4) at a flow rate of 3 BV / h. After the column loading was completed, it was eluted with 2 BV of 30 (v / v)% ethanol aqueous solution to obtain the elution solution. After de-alcoholization, the purified solution was obtained.

[0060] (5) The purified solution was concentrated under reduced pressure to a solid content of 40 wt%, and spray-dried. The drying conditions were set as follows: inlet temperature 160 ℃ and outlet temperature 80 ℃ to obtain wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol.

[0061] The preparation method of broccoli stalk extract includes the following steps:

[0062] S1: Wash the broccoli stems (collected from the market, the discarded parts after removing the broccoli florets) with clean water, let them air dry naturally until there are no liquid droplets on the surface, add 3 times the weight of water, and grind them under ice bath conditions until the particle size is less than 100μm to obtain a slurry;

[0063] S2: The slurry was sonicated at 50℃ and 60Hz for 30 min, then centrifuged at 3000 rpm for 18 min. The centrifuged liquid was collected, concentrated under reduced pressure, and spray-dried to obtain broccoli stem extract with a water content of 1.76 wt%.

[0064] Comparative Example 1

[0065] The difference between this comparative example and Example 1 is that the ratio of viable Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110 and Lactobacillus gasseri LG-G12 in the compound microbial agent is 0.2:1.1:1.8.

[0066] Comparative Example 2

[0067] The difference between this comparative example and Example 1 is that the ratio of viable Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110 and Lactobacillus gasseri LG-G12 in the compound microbial agent is 0.6:0.7:1.4.

[0068] Comparative Example 3

[0069] The difference between this comparative example and Example 1 is that, referring to the extraction method of wolfberry peptide in CN 106868081 A, fermentation was replaced with enzymatic hydrolysis. Specifically, a wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol is prepared by the following steps:

[0070] (1) Dry fresh wolfberries (variety: Ningqi No. 1) to a moisture content of 8wt%, and grind them to less than 100 mesh to obtain wolfberry powder;

[0071] (2) Mix wolfberry powder and water at a mass ratio of 1:9, sterilize, and obtain a mixture. Add papain (papain, product number GC51809, Shanghai Guchen Biotechnology Co., Ltd.) at a volume mass ratio of 1:0.7 to the mixture, adjust the pH to 5.5, and enzymatically hydrolyze for 1.5 h at 50℃ and 800MHz. Then adjust the pH to 3.5 and add a complex polysaccharide enzyme (model) at a volume mass ratio of 0.4 to the mixture. L, Brand: SIGMA (USA), Distributor: Hangzhou Lianke Meixun Biomedical Technology Co., Ltd., was prepared by enzymatic hydrolysis at 45℃ and 800MHz for 1 hour, followed by enzyme inactivation at 95℃ for 15 seconds, and then cooling to room temperature.

[0072] (3) The enzymatic hydrolysate was sonicated at a power of 380W, a frequency of 334kHz, a temperature of 35℃, and a duration of 1.5h. The centrifugation speed was 2600r / min and the centrifugation time was 30min. The supernatant was then collected.

[0073] (4) The upper liquid was filtered using a microfiltration membrane with a molecular weight of 35kD. The permeate was collected at a pressure of 5 bar and a temperature of 40°C. The permeate was filtered using a microfiltration membrane with a molecular weight of 6kD. The retentate was collected at a pressure of 8 bar and a temperature of 30°C. The retentate was eluted using a macroporous adsorption resin column (filled with D101 resin and AB-8 resin in a mass ratio of 3:4) at a loading flow rate of 1.5 BV / h. The purified solution was collected.

[0074] (5) The purified solution was concentrated under reduced pressure to a solid content of 35wt%, and spray-dried. The drying conditions were set as follows: inlet temperature 160℃ and outlet temperature 80℃ to obtain wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol.

[0075] Comparative Example 4

[0076] The difference between this comparative example and Example 1 is that the broccoli stem extract was replaced with cabbage extract.

[0077] The preparation method of Chinese cabbage extract includes the following steps:

[0078] S1: Wash the cabbage leaves with clean water, air dry them naturally until there are no liquid droplets on the surface, add 3 times the weight of water, and grind them under ice bath conditions until the particle size is less than 100μm to obtain a slurry;

[0079] S2: The slurry was sonicated at 45℃ and 55Hz for 25 min, then centrifuged at 3000rpm for 18 min. The centrifuged liquid was collected, concentrated under reduced pressure, and spray-dried to obtain a Chinese cabbage extract with a water content of 2.05wt%.

[0080] Comparative Example 5

[0081] The difference between this comparative example and Example 1 is that the fermentation aid consists of xylose, alanine, calcium chloride and superphosphate in a mass ratio of 8:3:1:2.

[0082] Comparative Example 6

[0083] This comparative example is the goji berry peptide prepared in Example 1 of the extraction method of goji berry peptide in patent CN117737170A.

[0084] Comparative Example 7

[0085] This comparative example refers to the goji berry peptide prepared in Example 1 of the extraction method for goji berry peptide disclosed in patent CN106868081A.

[0086] Performance testing

[0087] The wolfberry peptides prepared in Examples 1-3 and Comparative Examples 1-7 were tested.

[0088] 1. Refer to the article "Determination of Glutathione in Lycium barbarum using Derivatization Reagent DTNB" (Zhu Yaling et al.) to determine the glutathione content in Lycium barbarum peptides. Glutathione content = mass of glutathione ÷ mass of Lycium barbarum peptides.

[0089] 2. Referring to the article "Lycium barbarum cyclic peptide regulates NLRP3 and NF-κB signaling pathways to alleviate BaP-induced inflammatory damage to airway epithelial cells" (Zhao Chuanxin et al.), the content of Lycium barbarum cyclic peptide-1 (LBP-1) in Lycium barbarum peptide was determined. The LBP-1 content = mass of LBP-1 ÷ mass of Lycium barbarum peptide.

[0090] The results are shown in Table 1.

[0091] Table 1 Test Results

[0092] Group Glutathione content (mg / g) LBP-1 content (mg / g) Example 1 33.13 18.40 Example 2 30.40 16.83 Example 3 31.54 17.26 Comparative Example 1 27.21 15.15 Comparative Example 2 28.65 15.47 Comparative Example 3 25.94 13.31 Comparative Example 4 24.73 13.79 Comparative Example 5 25.48 15.36 Comparative Example 6 22.63 14.28 Comparative Example 7 20.86 12.53

[0093] 2. Experimental animals: 50 male spontaneously hypertensive rats (SHR) aged 10 weeks, weighing 180-220g. Another 10 age-matched normotensive WistarKyoto (WKY) rats weighing 180-220g were used as a control group.

[0094] Group design: Fifty SHR rats were randomly divided into 5 groups (model control group, positive drug control group, Example 1 group, and comparative examples 6-7 groups), with 10 rats in each group. WKY rats were assigned to 1 group (blank group), with 10 rats in each group.

[0095] Model control group: administered an equal volume of physiological saline by gavage.

[0096] Positive control group: Captopril (10 mg / kg / day) administered by gavage.

[0097] Example 1 group: Gavage administration of wolfberry peptide (400mg / kg / day) as in Example 1.

[0098] Comparative Example 6: Comparative Example 6: Lycium barbarum peptide (400mg / kg / day) administered by gavage.

[0099] Comparative Example 7: Comparative Example 7 Lycium barbarum peptide (400mg / kg / day) was administered by gavage.

[0100] Control group (WKY): Gavaged with an equal volume of physiological saline.

[0101] All gavage treatments lasted for 8 weeks.

[0102] The results are shown in Table 2.

[0103] Table 2 Blood Pressure Test Results

[0104]

[0105] As shown in Tables 1 and 2, the wolfberry peptides in Examples 1-3 have high contents of glutathione and wolfberry cyclic peptide-1, and the blood pressure lowering effect of wolfberry peptides is better than that of products in the prior art.

[0106] Comparative Examples 1-3 show that the ratio of compound microbial agents affects the content of glutathione and cyclic peptide-1 in wolfberry peptides, thus affecting the blood pressure lowering effect of wolfberry peptides.

[0107] Comparative Examples 4-5 show that fermentation aids affect the fermentation effect of compound microbial agents, which in turn affects the content of glutathione and wolfberry cyclic peptide-1.

[0108] The above description represents the preferred embodiments of the present invention. It should be noted that those skilled in the art can make various improvements and modifications without departing from the principles of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.

Claims

1. A method for simultaneously increasing the content of glutathione and LBP-1 in wolfberry peptides, characterized in that, Includes the following steps: (1) Dry fresh wolfberries, pulverize them, and obtain wolfberry powder; (2) Mix wolfberry powder, water and fermentation aid, sterilize to obtain a mixture, add compound microbial agent to the mixture, anaerobic fermentation, sterilize to obtain fermentation product; (3) Sonicate the fermentation product, centrifuge, and collect the supernatant liquid; (4) The upper liquid was filtered through a microfiltration membrane and eluted with a macroporous adsorption resin column in sequence to obtain a purified solution; (5) The purified solution was concentrated under reduced pressure and spray-dried to obtain wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol; The compound microbial agent includes Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110 and Lactobacillus gasseri LG-G12 with a live bacteria count ratio of (0.3-0.5):(0.8-1.0):(1.5-1.7); The fermentation aids consist of sucrose, broccoli stem extract, calcium nitrate, calcium chloride, and arginine in a mass ratio of (10-12):(3-4):(1-3):(0.5-1.5):(0.1-0.3). The preparation method of broccoli stalk extract includes the following steps: S1: Wash the broccoli stems, let them air dry until there are no liquid droplets on the surface, add water, grind, and obtain a slurry; S2: Sonicate the slurry at 40-50℃ and 50-60Hz for 20-30 minutes, centrifuge, collect the centrifuged liquid, concentrate under reduced pressure, and spray dry to obtain broccoli stem extract.

2. The application of broccoli stalk extract as a fermentation aid in simultaneously increasing the content of glutathione and LBP-1 in wolfberry peptides, characterized in that... The preparation method of broccoli stalk extract includes the following steps: S1: Wash the broccoli stems, let them air dry until there are no liquid droplets on the surface, add water, grind, and obtain a slurry; S2: Sonicate the slurry at 40-50℃ and 50-60Hz for 20-30 minutes, centrifuge, collect the centrifuged liquid, concentrate under reduced pressure, and spray dry to obtain broccoli stem extract; The steps of the application include: (1) Dry fresh wolfberries, pulverize them, and obtain wolfberry powder; (2) Mix wolfberry powder, water and fermentation aid, sterilize to obtain a mixture, add compound microbial agent to the mixture, anaerobic fermentation, sterilize to obtain fermentation product; (3) Sonicate the fermentation product, centrifuge, and collect the supernatant liquid; (4) The upper liquid was filtered through a microfiltration membrane and eluted with a macroporous adsorption resin column in sequence to obtain a purified solution; (5) The purified solution was concentrated under reduced pressure and spray-dried to obtain wolfberry peptide with the effect of lowering blood pressure, blood sugar, and cholesterol; The compound microbial agent includes Lactobacillus acidophilus A-G80, Lactobacillus paracasei LPc-G110 and Lactobacillus gasseri LG-G12 with a live bacteria count ratio of (0.3-0.5):(0.8-1.0):(1.5-1.7); The fermentation aids consist of sucrose, broccoli stem extract, calcium nitrate, calcium chloride, and arginine in a mass ratio of (10-12):(3-4):(1-3):(0.5-1.5):(0.1-0.3).

3. The method according to claim 1 or the application according to claim 2, characterized in that, The dosage of the compound microbial agent is (5-8) × 10. 7 CFU / mL mixture.

4. The method according to claim 1 or the application according to claim 2, wherein the anaerobic fermentation conditions are: anaerobic fermentation at 35-40℃ for 72-84 hours.

5. The method according to claim 1 or the application according to claim 2, wherein the ultrasonic conditions are: ultrasonic power of 350-400W, ultrasonic frequency of 32-35kHz, ultrasonic temperature of 30-40°C, and ultrasonic time of 1-2h.

Citation Information

Patent Citations

  • Cyclic peptides with vasodilator action, preparation and uses thereof

    CN101289494B

  • Extraction method for medlar peptide

    CN106868081A

  • Extraction method of wolfberry peptide

    CN117737170A

  • Preparation method of high-purity lycium polysaccharides

    CN110066313A

  • Fermentation method for preparing Chinese wolfberry active peptide, method, application, inhibitor and functional food

    CN112442104A